203 related articles for article (PubMed ID: 33627422)
1. Functional antagonism of chromatin modulators regulates epithelial-mesenchymal transition.
Serresi M; Kertalli S; Li L; Schmitt MJ; Dramaretska Y; Wierikx J; Hulsman D; Gargiulo G
Sci Adv; 2021 Feb; 7(9):. PubMed ID: 33627422
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic coordination of signaling pathways during the epithelial-mesenchymal transition.
Cieślik M; Hoang SA; Baranova N; Chodaparambil S; Kumar M; Allison DF; Xu X; Wamsley JJ; Gray L; Jones DR; Mayo MW; Bekiranov S
Epigenetics Chromatin; 2013 Sep; 6(1):28. PubMed ID: 24004852
[TBL] [Abstract][Full Text] [Related]
3. Whole-genome multiparametric screening to identify modulators of epithelial-to-mesenchymal transition.
Said NA; Gould CM; Lackovic K; Simpson KJ; Williams ED
Assay Drug Dev Technol; 2014 Sep; 12(7):385-94. PubMed ID: 25181411
[TBL] [Abstract][Full Text] [Related]
4. Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer.
Yun J; Song SH; Kim HP; Han SW; Yi EC; Kim TY
EMBO Rep; 2016 Sep; 17(9):1343-59. PubMed ID: 27466323
[TBL] [Abstract][Full Text] [Related]
5. Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes.
Basu M; Sengupta I; Khan MW; Srivastava DK; Chakrabarti P; Roy S; Das C
Biochem J; 2017 May; 474(11):1919-1934. PubMed ID: 28432260
[TBL] [Abstract][Full Text] [Related]
6. Peroxiredoxin-6 regulates p38-mediated epithelial-mesenchymal transition in HCT116 colon cancer cells.
Chae U; Kim B; Kim H; Park YH; Lee SH; Kim SU; Lee DS
J Biol Res (Thessalon); 2021 Nov; 28(1):22. PubMed ID: 34814951
[TBL] [Abstract][Full Text] [Related]
7. SNAIL1-mediated downregulation of FOXA proteins facilitates the inactivation of transcriptional enhancer elements at key epithelial genes in colorectal cancer cells.
Jägle S; Busch H; Freihen V; Beyes S; Schrempp M; Boerries M; Hecht A
PLoS Genet; 2017 Nov; 13(11):e1007109. PubMed ID: 29155818
[TBL] [Abstract][Full Text] [Related]
8. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
[TBL] [Abstract][Full Text] [Related]
9. Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial-Mesenchymal Transition.
Fang L; Zhang L; Wang M; He Y; Yang J; Huang Z; Tan Y; Fang K; Li J; Sun Z; Li Y; Tang Y; Liang W; Cui H; Zhu Q; Wu Z; Li Y; Hu Y; Chen W
Cancer Res; 2024 Mar; 84(5):659-674. PubMed ID: 38190710
[TBL] [Abstract][Full Text] [Related]
10. Chromatinized protein kinase C-θ directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells.
Zafar A; Wu F; Hardy K; Li J; Tu WJ; McCuaig R; Harris J; Khanna KK; Attema J; Gregory PA; Goodall GJ; Harrington K; Dahlstrom JE; Boulding T; Madden R; Tan A; Milburn PJ; Rao S
Mol Cell Biol; 2014 Aug; 34(16):2961-80. PubMed ID: 24891615
[TBL] [Abstract][Full Text] [Related]
11. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
Ruscetti M; Dadashian EL; Guo W; Quach B; Mulholland DJ; Park JW; Tran LM; Kobayashi N; Bianchi-Frias D; Xing Y; Nelson PS; Wu H
Oncogene; 2016 Jul; 35(29):3781-95. PubMed ID: 26640144
[TBL] [Abstract][Full Text] [Related]
12. ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion.
Wilson MR; Reske JJ; Holladay J; Wilber GE; Rhodes M; Koeman J; Adams M; Johnson B; Su RW; Joshi NR; Patterson AL; Shen H; Leach RE; Teixeira JM; Fazleabas AT; Chandler RL
Nat Commun; 2019 Aug; 10(1):3554. PubMed ID: 31391455
[TBL] [Abstract][Full Text] [Related]
13. AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancer.
Qiao Y; Shiue CN; Zhu J; Zhuang T; Jonsson P; Wright AP; Zhao C; Dahlman-Wright K
Oncotarget; 2015 Apr; 6(10):7804-14. PubMed ID: 25762639
[TBL] [Abstract][Full Text] [Related]
14. MAP3K4 Controls the Chromatin Modifier HDAC6 during Trophoblast Stem Cell Epithelial-to-Mesenchymal Transition.
Mobley RJ; Raghu D; Duke LD; Abell-Hart K; Zawistowski JS; Lutz K; Gomez SM; Roy S; Homayouni R; Johnson GL; Abell AN
Cell Rep; 2017 Mar; 18(10):2387-2400. PubMed ID: 28273454
[TBL] [Abstract][Full Text] [Related]
15. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
[TBL] [Abstract][Full Text] [Related]
16. Cell-Type-Specific Chromatin States Differentially Prime Squamous Cell Carcinoma Tumor-Initiating Cells for Epithelial to Mesenchymal Transition.
Latil M; Nassar D; Beck B; Boumahdi S; Wang L; Brisebarre A; Dubois C; Nkusi E; Lenglez S; Checinska A; Vercauteren Drubbel A; Devos M; Declercq W; Yi R; Blanpain C
Cell Stem Cell; 2017 Feb; 20(2):191-204.e5. PubMed ID: 27889319
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics.
Chaves LP; Melo CM; Saggioro FP; Reis RBD; Squire JA
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946849
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome Atlas.
Gibbons DL; Creighton CJ
Dev Dyn; 2018 Mar; 247(3):555-564. PubMed ID: 28073171
[TBL] [Abstract][Full Text] [Related]
19. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120).
Huang RY; Kuay KT; Tan TZ; Asad M; Tang HM; Ng AH; Ye J; Chung VY; Thiery JP
Oncotarget; 2015 Sep; 6(26):22098-113. PubMed ID: 26061747
[TBL] [Abstract][Full Text] [Related]
20. Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT.
Lee J; Kim H; Lee JE; Shin SJ; Oh S; Kwon G; Kim H; Choi YY; White MA; Paik S; Cheong JH; Kim HS
Gastroenterology; 2018 Sep; 155(3):799-814.e13. PubMed ID: 29775598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
